STEFFEN THIEL: Innate Immune system

Steffen Thiel’s research focus is the processes that create inflammation in the body and his group is among the leaders in the field of immune recognition.

Steffen Thiel has been deeply involved in the description of the proteins and processes in the part of the immune system referred to as the complement system.

Recent publications

Sort by: Date | Author | Title

Kuijper, E. J., Fijen, C. A., Dankert, J. & Thiel, S. (1999). Mannose-binding lectin and meningococcal disease. Lancet, 354(9175), 338. https://doi.org/10.1016/S0140-6736(05)75244-2

Tang, C., Kwiatkowski, D., Garred, P., Madsen, H. O., Svejgaard, A., Michaelsen, T. E., Hibberd, M. L., Sumiya, M., Summerfield, J. A., Booy, R., Levin, M., Van Helden, P., Hoal-van Helden, E., Kuijper, E. J., Fijen, C. A., Dankert, J., Thiel, S., Megyeri, P., Deli, M. A. & Abraham, C. S. (1999). Mannose-binding lectin and meningococcal disease (multiple letters) [3]. Lancet, 354(9175), 336-338. https://doi.org/10.1016/S0140-6736(05)75240-5

Jensenius, J. C. & Thiel, S. (1999). MASP-3: an MBL-associated serine protease and uses for it. (Patent No. PA 1999 01721).

Vorup-Jensen, T., Thiel, S. & Jensenius, J. C. (1999). Recombinant Human Mannan Binding Lectin. (Patent No. PA 1999 00668).

Stover, C. M., Thiel, S., Lynch, N. J. & Schwaeble, W. J. (1999). The rat and mouse homologues of MASP-2 and MAp19, components of the lectin activation pathway of complement. Journal of Immunology, 163(12), 6848-59.

Displaying results 451 to 455 out of 512

Full list of publications

Group leader

Group members

Postal Address

Interdisciplinary Nanoscience Center (iNANO)

Gustav Wieds Vej 14

8000 Aarhus C

Denmark

Revised 08.12.2025

Rikke Ploug Frydenberg